Barbara Tilley to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Barbara Tilley has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.386
-
An efficient multi-stage, single-arm Phase II futility design for ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep; 5 Suppl 1:55-6.
Score: 0.234
-
Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 2006 Mar 14; 66(5):628-33.
Score: 0.065
-
Applying a phase II futility study design to therapeutic stroke trials. Stroke. 2005 Nov; 36(11):2410-4.
Score: 0.063
-
Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale. Parkinsonism Relat Disord. 2012 Mar; 18(3):230-3.
Score: 0.024